Quantitative Pulmonary Imaging Registry & Biorepository
PIBR
1 other identifier
observational
100
1 country
1
Brief Summary
The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological significance of imaging biomarkers. This registry and biorepository will accelerate the development of these imaging techniques and may lead toward future clinical adoption of quantitative pulmonary imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 24, 2022
CompletedFirst Submitted
Initial submission to the registry
September 2, 2022
CompletedFirst Posted
Study publicly available on registry
September 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2028
May 6, 2026
April 1, 2026
5.6 years
September 2, 2022
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Collect Clinical Data
Collect relevant medical history (including demographic information, diagnoses, medical tests, smoking history), for patients participating in pulmonary imaging research.
From Enrollment to 3 Months
Establish a Biorepository
Establish a collection of biospecimens from imaging subjects to foster an improved understanding of the physiological significance of imaging biomarkers.
From Enrollment to 3 Months
Biospecimen Collection
Correlate imaging biomarkers with biospecimens and physiological/vital signs data.
From Enrollment to 6 Months
Collaborate
Provide images and biospecimens to researchers working to develop analysis methods for pulmonary CT and MRI. Separate IRB approval, alongside appropriate data and/or materials transfer agreements will be needed for these studies.
From Enrollment to 12 Months
Eligibility Criteria
Participating in an Imaging Study at KUMC
You may qualify if:
- The participant is enrolling/has enrolled in a research study at the University of Kansas Medical Center that involves Pulmonary MRI and/or Pulmonary CT.
You may not qualify if:
- The participant declines to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter J Niedbalski, PhD
Research Assistant Professor
- STUDY DIRECTOR
Luigi R Boccardi, MPH
Director of Pulmonary, Critical Care, & Sleep Research
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
September 2, 2022
First Posted
September 7, 2022
Study Start
May 24, 2022
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
May 31, 2028
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Access Criteria
- Contact Peter J. Niedbalski, PhD to discuss accessing IPD.
Collaborators at KUMC that are not on the study team may request access to identified or deidentified data/biospecimens from this project. Collaborators may include parties outside of KUMC, in which case only deidentified data will be shared. When potential collaborators request access to data and/or biospecimens, the following will be considered: research question and study design, timing of request, and amount of specimen needed. Corporate entities will not be allowed access to data or samples from the biobank.